These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 2684471)

  • 1. Pharmacokinetic implications for the clinical use of propofol.
    Kanto J; Gepts E
    Clin Pharmacokinet; 1989 Nov; 17(5):308-26. PubMed ID: 2684471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of the newer intravenous anaesthetic agents.
    Davis PJ; Cook DR
    Clin Pharmacokinet; 1986; 11(1):18-35. PubMed ID: 3512140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of the induction dose of propofol in chronic renal failure patients undergoing renal transplantation.
    de Gasperi A; Mazza E; Noè L; Corti A; Cristalli A; Prosperi M; Sabbadini D; Savi MC; Vai S
    Minerva Anestesiol; 1996; 62(1-2):25-31. PubMed ID: 8768021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fentanyl pre-treatment does not affect the pharmacokinetic profile of an induction dose of propofol in adults.
    De Gasperi A; Cristalli A; Noé L; Sabbadini D; Mazza E; Prosperi M; Fantini G; Crespi AM; Rezzani S
    Eur J Anaesthesiol; 1994 Mar; 11(2):89-93. PubMed ID: 8174540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients.
    Frenkel C; Schuttler J; Ihmsen H; Heye H; Rommelsheim K
    Intensive Care Med; 1995 Dec; 21(12):981-8. PubMed ID: 8750122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol.
    Simons PJ; Cockshott ID; Douglas EJ; Gordon EA; Hopkins K; Rowland M
    Xenobiotica; 1988 Apr; 18(4):429-40. PubMed ID: 3261062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain.
    Hiraoka H; Yamamoto K; Miyoshi S; Morita T; Nakamura K; Kadoi Y; Kunimoto F; Horiuchi R
    Br J Clin Pharmacol; 2005 Aug; 60(2):176-82. PubMed ID: 16042671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution in female rats of an anaesthetic intravenous dose of 14C-propofol.
    Simons PJ; Cockshott ID; Douglas EJ; Gordon EA; Knott S; Ruane RJ
    Xenobiotica; 1991 Oct; 21(10):1325-35. PubMed ID: 1796609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of etomidate].
    Levron JC; Assoune P
    Ann Fr Anesth Reanim; 1990; 9(2):123-6. PubMed ID: 2363548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse effects and recovery after total intravenous anesthesia in children].
    Drasković B; Cvejanov M
    Med Pregl; 1998; 51(1-2):68-72. PubMed ID: 9531778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent development of acute tolerance to propofol and its distribution in a pharmacokinetic compartment-independent rat model.
    Larsson JE; Wahlström G
    Acta Anaesthesiol Scand; 1996 Jul; 40(6):734-40. PubMed ID: 8836271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol clearance in morbidly obese children and adolescents: influence of age and body size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perioperative management with short-acting intravenous anesthetics].
    Hachenberg T
    Anaesthesiol Reanim; 2000; 25(6):144-50. PubMed ID: 11194382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol, the newest induction agent of anesthesia.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):41-57. PubMed ID: 3042641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of propofol: a multicenter study.
    Schüttler J; Ihmsen H
    Anesthesiology; 2000 Mar; 92(3):727-38. PubMed ID: 10719952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.